This video is entirely AI generated and does not replicate any original material. It should not be considered a substitute for authentic sources. For complete context and techniques, viewers are encouraged to refer to the original content.
Based on findings from:
-
Accelerating Innovation (AI) for Kids With Cancer Act
-
Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes
Darui Jin, et al.. Nature Cancer, 2026.
DOI: 10.1038/s43018-026-01186-3
-
Joint Commission Releases First of Its Kind Exclusively Designed for Healthcare Organizations, Voluntary Responsible Use of AI in Healthcare Certification
Weekly News Brief: July 13–17, 2026
To catch up on all of the news from this past week, listen to our weekly news brief for the week of July 13–17, 2026..
This week’s brief covers a bipartisan House bill to accelerate pediatric cancer research with AI, an AI model that predicts CNS tumor subtypes from histology slides, and a new Joint Commission voluntary certification program for responsible AI use in health care.
To learn more about the AI for Kids With Cancer Act, read "House Bill Seeks to Accelerate Pediatric Cancer Research With AI," or see the bill.
For more information on Hetairos, read "AI Model Predicts CNS Tumor Subtypes From Routine Histology Slides," or see the source report in Nature Cancer.
To learn more about the RUAIH certification, read "Joint Commission Launches Voluntary Certification for Responsible AI Use in Health Care," or see the news release.
Disclaimer: This newscast was generated with the assistance of AI tools and avatars. All content is reviewed and approved by the editorial staff of ASCO AI in Oncology. Contact us with any questions.
The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. The mention of any company, product, service, or therapy should not be construed as an endorsement of any kind. Conexiant and ASCO assume no responsibility for any injury or damage to persons or property arising out of or related to any use of material contained in this publication or to any errors or omissions.